Cohort profile: EFTER-COVID – a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Cohort profile : EFTER-COVID – a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic. / Sørensen, Anna Irene Vedel; Bager, Peter; Nielsen, Nete Munk; Koch, Anders; Spiliopoulos, Lampros; Hviid, Anders; Ethelberg, Steen.

I: BMJ Open, Bind 14, Nr. 5, e087799, 2024.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Sørensen, AIV, Bager, P, Nielsen, NM, Koch, A, Spiliopoulos, L, Hviid, A & Ethelberg, S 2024, 'Cohort profile: EFTER-COVID – a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic', BMJ Open, bind 14, nr. 5, e087799. https://doi.org/10.1136/bmjopen-2024-087799

APA

Sørensen, A. I. V., Bager, P., Nielsen, N. M., Koch, A., Spiliopoulos, L., Hviid, A., & Ethelberg, S. (2024). Cohort profile: EFTER-COVID – a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic. BMJ Open, 14(5), [e087799]. https://doi.org/10.1136/bmjopen-2024-087799

Vancouver

Sørensen AIV, Bager P, Nielsen NM, Koch A, Spiliopoulos L, Hviid A o.a. Cohort profile: EFTER-COVID – a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic. BMJ Open. 2024;14(5). e087799. https://doi.org/10.1136/bmjopen-2024-087799

Author

Sørensen, Anna Irene Vedel ; Bager, Peter ; Nielsen, Nete Munk ; Koch, Anders ; Spiliopoulos, Lampros ; Hviid, Anders ; Ethelberg, Steen. / Cohort profile : EFTER-COVID – a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic. I: BMJ Open. 2024 ; Bind 14, Nr. 5.

Bibtex

@article{1e10eb5427454b0590b91635f8ce96c2,
title = "Cohort profile: EFTER-COVID – a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic",
abstract = "Purpose To follow SARS-CoV-2-infected persons up to 18 months after a positive test in order to assess the burden and nature of post acute symptoms and health problems. Participants Persons in Denmark above 15 years of age, who were tested positive for SARS-CoV-2 during 1 September 2020 to 21 February 2023 using a RT-PCR test. As a reference group, three test-negative individuals were selected for every two test-positive individuals by matching on test date. Findings to date In total, 2 427 913 invitations to baseline questionnaires have been sent out and 839 528 baseline questionnaires (34.5%) have been completed. Females, the age group 50–69 years, Danish-born and persons, who had received at least one SARS-CoV-2 vaccination booster dose were more likely to participate. Follow-up questionnaires were sent at 2, 4, 6, 9, 12 and 18 months after the test, with response rates at 42%–54%. Future plans New participants have been recruited on a daily basis from 1 August 2021 to 23 March 2023. Data collection will continue until the last follow-up questionnaires (at 18 months after test) have been distributed in August 2024.",
keywords = "COVID-19, EPIDEMIOLOGY, Epidemiology",
author = "S{\o}rensen, {Anna Irene Vedel} and Peter Bager and Nielsen, {Nete Munk} and Anders Koch and Lampros Spiliopoulos and Anders Hviid and Steen Ethelberg",
note = "Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2024.",
year = "2024",
doi = "10.1136/bmjopen-2024-087799",
language = "English",
volume = "14",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "5",

}

RIS

TY - JOUR

T1 - Cohort profile

T2 - EFTER-COVID – a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic

AU - Sørensen, Anna Irene Vedel

AU - Bager, Peter

AU - Nielsen, Nete Munk

AU - Koch, Anders

AU - Spiliopoulos, Lampros

AU - Hviid, Anders

AU - Ethelberg, Steen

N1 - Publisher Copyright: © Author(s) (or their employer(s)) 2024.

PY - 2024

Y1 - 2024

N2 - Purpose To follow SARS-CoV-2-infected persons up to 18 months after a positive test in order to assess the burden and nature of post acute symptoms and health problems. Participants Persons in Denmark above 15 years of age, who were tested positive for SARS-CoV-2 during 1 September 2020 to 21 February 2023 using a RT-PCR test. As a reference group, three test-negative individuals were selected for every two test-positive individuals by matching on test date. Findings to date In total, 2 427 913 invitations to baseline questionnaires have been sent out and 839 528 baseline questionnaires (34.5%) have been completed. Females, the age group 50–69 years, Danish-born and persons, who had received at least one SARS-CoV-2 vaccination booster dose were more likely to participate. Follow-up questionnaires were sent at 2, 4, 6, 9, 12 and 18 months after the test, with response rates at 42%–54%. Future plans New participants have been recruited on a daily basis from 1 August 2021 to 23 March 2023. Data collection will continue until the last follow-up questionnaires (at 18 months after test) have been distributed in August 2024.

AB - Purpose To follow SARS-CoV-2-infected persons up to 18 months after a positive test in order to assess the burden and nature of post acute symptoms and health problems. Participants Persons in Denmark above 15 years of age, who were tested positive for SARS-CoV-2 during 1 September 2020 to 21 February 2023 using a RT-PCR test. As a reference group, three test-negative individuals were selected for every two test-positive individuals by matching on test date. Findings to date In total, 2 427 913 invitations to baseline questionnaires have been sent out and 839 528 baseline questionnaires (34.5%) have been completed. Females, the age group 50–69 years, Danish-born and persons, who had received at least one SARS-CoV-2 vaccination booster dose were more likely to participate. Follow-up questionnaires were sent at 2, 4, 6, 9, 12 and 18 months after the test, with response rates at 42%–54%. Future plans New participants have been recruited on a daily basis from 1 August 2021 to 23 March 2023. Data collection will continue until the last follow-up questionnaires (at 18 months after test) have been distributed in August 2024.

KW - COVID-19

KW - EPIDEMIOLOGY

KW - Epidemiology

U2 - 10.1136/bmjopen-2024-087799

DO - 10.1136/bmjopen-2024-087799

M3 - Journal article

C2 - 38719312

AN - SCOPUS:85192644851

VL - 14

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 5

M1 - e087799

ER -

ID: 392980355